Literature DB >> 19948097

Diastolic and systolic heart failure: different stages or distinct phenotypes of the heart failure syndrome?

Jean G F Bronzwaer1, Walter J Paulus.   

Abstract

It remains uncertain if diastolic heart failure (DHF) is a distinct HF phenotype or a precursor stage of systolic HF (SHF). The unimodal distribution of left ventricular ejection fraction (LVEF) in HF, depressed LV long-axis shortening in DHF, and progression to eccentric LV remodeling in hypertension favor DHF and SHF as successive stages. These arguments are countered by the bimodal distribution of LVEF after correction for gender, by the preserved LV twist in DHF and by the low incidence of eccentric LV remodeling in hypertension. Clinical features, LV anatomy and histology, cardiomyocyte stiffness, myocardial effects of diabetes, and the response to HF therapy support DHF and SHF as distinct phenotypes. Comparison of the myocardial signal transduction cascades that drive LV remodeling in DHF and SHF may solve the controversy. This review analyzes arguments supporting DHF and SHF as successive stages or distinct phenotypes of the HF syndrome.

Entities:  

Mesh:

Year:  2009        PMID: 19948097     DOI: 10.1007/s11897-009-0038-0

Source DB:  PubMed          Journal:  Curr Heart Fail Rep        ISSN: 1546-9530


  35 in total

1.  Matrix metalloproteinases/tissue inhibitors of metalloproteinases: relationship between changes in proteolytic determinants of matrix composition and structural, functional, and clinical manifestations of hypertensive heart disease.

Authors:  S Hinan Ahmed; Leslie L Clark; Weems R Pennington; Carson S Webb; D Dirk Bonnema; Amy H Leonardi; Catherine D McClure; Francis G Spinale; Michael R Zile
Journal:  Circulation       Date:  2006-04-24       Impact factor: 29.690

2.  Transcriptional and posttranslational modifications of titin: implications for diastole.

Authors:  Attila Borbély; Loek van Heerebeek; Walter J Paulus
Journal:  Circ Res       Date:  2009-01-02       Impact factor: 17.367

3.  Statin therapy may be associated with lower mortality in patients with diastolic heart failure: a preliminary report.

Authors:  Hidekatsu Fukuta; David C Sane; Steffen Brucks; William C Little
Journal:  Circulation       Date:  2005-07-11       Impact factor: 29.690

4.  Myocardial structure and function differ in systolic and diastolic heart failure.

Authors:  Loek van Heerebeek; Attila Borbély; Hans W M Niessen; Jean G F Bronzwaer; Jolanda van der Velden; Ger J M Stienen; Wolfgang A Linke; Gerrit J Laarman; Walter J Paulus
Journal:  Circulation       Date:  2006-04-17       Impact factor: 29.690

5.  Hypophosphorylation of the Stiff N2B titin isoform raises cardiomyocyte resting tension in failing human myocardium.

Authors:  Attila Borbély; Ines Falcao-Pires; Loek van Heerebeek; Nazha Hamdani; István Edes; Cristina Gavina; Adelino F Leite-Moreira; Jean G F Bronzwaer; Zoltán Papp; Jolanda van der Velden; Ger J M Stienen; Walter J Paulus
Journal:  Circ Res       Date:  2009-01-29       Impact factor: 17.367

6.  Novel metabolic risk factors for incident heart failure and their relationship with obesity: the MESA (Multi-Ethnic Study of Atherosclerosis) study.

Authors:  Hossein Bahrami; David A Bluemke; Richard Kronmal; Alain G Bertoni; Donald M Lloyd-Jones; Eyal Shahar; Moyses Szklo; João A C Lima
Journal:  J Am Coll Cardiol       Date:  2008-05-06       Impact factor: 24.094

7.  Diastolic stiffness of the failing diabetic heart: importance of fibrosis, advanced glycation end products, and myocyte resting tension.

Authors:  Loek van Heerebeek; Nazha Hamdani; M Louis Handoko; Ines Falcao-Pires; René J Musters; Koba Kupreishvili; Alexander J J Ijsselmuiden; Casper G Schalkwijk; Jean G F Bronzwaer; Michaela Diamant; Attila Borbély; Jolanda van der Velden; Ger J M Stienen; Gerrit J Laarman; Hans W M Niessen; Walter J Paulus
Journal:  Circulation       Date:  2007-12-10       Impact factor: 29.690

8.  Hospitalization for heart failure in the presence of a normal left ventricular ejection fraction: results of the New York Heart Failure Registry.

Authors:  Marc Klapholz; Matthew Maurer; April M Lowe; Frank Messineo; Jay S Meisner; Judith Mitchell; Jill Kalman; Robert A Phillips; Richard Steingart; Edward J Brown; Robert Berkowitz; Robert Moskowitz; Anita Soni; Donna Mancini; Rachel Bijou; Khashayar Sehhat; Nikita Varshneya; Marrick Kukin; Stuart D Katz; Lynn A Sleeper; Thierry H Le Jemtel
Journal:  J Am Coll Cardiol       Date:  2004-04-21       Impact factor: 24.094

9.  How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology.

Authors:  Walter J Paulus; Carsten Tschöpe; John E Sanderson; Cesare Rusconi; Frank A Flachskampf; Frank E Rademakers; Paolo Marino; Otto A Smiseth; Gilles De Keulenaer; Adelino F Leite-Moreira; Attila Borbély; István Edes; Martin Louis Handoko; Stephane Heymans; Natalia Pezzali; Burkert Pieske; Kenneth Dickstein; Alan G Fraser; Dirk L Brutsaert
Journal:  Eur Heart J       Date:  2007-04-11       Impact factor: 29.983

10.  Irbesartan in patients with heart failure and preserved ejection fraction.

Authors:  Barry M Massie; Peter E Carson; John J McMurray; Michel Komajda; Robert McKelvie; Michael R Zile; Susan Anderson; Mark Donovan; Erik Iverson; Christoph Staiger; Agata Ptaszynska
Journal:  N Engl J Med       Date:  2008-11-11       Impact factor: 91.245

View more
  7 in total

Review 1.  How should we measure global and regional left ventricular systolic function?

Authors:  Anders Sahlen; Reidar Winter
Journal:  J Echocardiogr       Date:  2011-03-23

2.  Rationale and Study Design of Differences in Cardiopulmonary Exercise Capacity According to Coronary Microvascular Dysfunction and Body Composition in Patients with Suspected Heart Failure with Preserved Ejection Fraction.

Authors:  So Ree Kim; Dong-Hyuk Cho; Mi-Na Kim; Seong-Mi Park
Journal:  Int J Heart Fail       Date:  2021-09-14

3.  Neuropsychological patterns differ by type of left ventricle dysfunction in heart failure.

Authors:  Lisa C Bratzke-Bauer; Bunny J Pozehl; Steven M Paul; Julene K Johnson
Journal:  Arch Clin Neuropsychol       Date:  2012-12-17       Impact factor: 2.813

Review 4.  A systematic review concerning the relation between the sympathetic nervous system and heart failure with preserved left ventricular ejection fraction.

Authors:  Willemien L Verloop; Martine M A Beeftink; Bernadet T Santema; Michiel L Bots; Peter J Blankestijn; Maarten J Cramer; Pieter A Doevendans; Michiel Voskuil
Journal:  PLoS One       Date:  2015-02-06       Impact factor: 3.240

Review 5.  Thrombospondins: A Role in Cardiovascular Disease.

Authors:  Dimitry A Chistiakov; Alexandra A Melnichenko; Veronika A Myasoedova; Andrey V Grechko; Alexander N Orekhov
Journal:  Int J Mol Sci       Date:  2017-07-17       Impact factor: 5.923

6.  Changes in Myocardial Microstructure and Mechanics With Progressive Left Ventricular Pressure Overload.

Authors:  William M Torres; Shayne C Barlow; Amber Moore; Lisa A Freeburg; Abigail Hoenes; Heather Doviak; Michael R Zile; Tarek Shazly; Francis G Spinale
Journal:  JACC Basic Transl Sci       Date:  2020-04-29

Review 7.  FIB-4 stage of liver fibrosis is associated with incident heart failure with preserved, but not reduced, ejection fraction among people with and without HIV or hepatitis C.

Authors:  Kaku A So-Armah; Joseph K Lim; Vincent Lo Re; Janet P Tate; Chung-Chou H Chang; Adeel A Butt; Cynthia L Gibert; David Rimland; Vincent C Marconi; Matthew Bidwell Goetz; Vasan Ramachandran; Evan Brittain; Michelle Long; Kim-Lien Nguyen; Maria C Rodriguez-Barradas; Matthew J Budoff; Hilary A Tindle; Jeffrey H Samet; Amy C Justice; Matthew S Freiberg
Journal:  Prog Cardiovasc Dis       Date:  2020-02-15       Impact factor: 11.278

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.